LATEST HEALTH NEWS
USFDA has approved an antibody-drug conjugate (Adcetris) in combination with chemotherapy as first-line treatment for stage III or IV classical Hodgkin lymphoma.
from Medindia Health News https://ift.tt/2GbmvA3
USFDA has approved an antibody-drug conjugate (Adcetris) in combination with chemotherapy as first-line treatment for stage III or IV classical Hodgkin lymphoma.
from Medindia Health News https://ift.tt/2GbmvA3
No comments
Thanks for comment via will connect you within 24 hours.